Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours.

Br J Cancer · 2003 · PMC2394431 · PMID 14612898

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A K trans reduction of approximately 30% ( P <0.001) was evident with 50 and 100 mg kg −1 ZD6474, a reduction of 12.5% ( P <0.05) at 25 mg kg −1 , and a reduction that did not reach statistical significance at 12.5 mg kg −1 .

also in 111,027 other papers

highly significantno p-value reported

Interestingly, ZD6474 has also demonstrated a highly significant effect on tumour growth and metastasis in this particular model ( Drevs et al , 2002b ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.